Siena Biotech S.p.A.
http://www.sienabiotech.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Siena Biotech S.p.A.
Pipeline Watch: Phase III Progress With Avelumab, Ixekizumab And Eravacycline
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Debiopharm taps Singapore expertise for epigenetic drug discovery deal
Debiopharm has entered into a basic research collaboration with the Experimental Therapeutics Centre (ETC) of Singapore's Agency for Science, Technology and Research (A*STAR), to develop oral small molecule modulators of epigenetic function.
Merck gets BACE boost in Alzheimer's race
Merck & Co's MK-8931 has successfully cleared an early hurdle in the race to find a product that might treat Alzheimer's disease through beta secretase enzyme (BACE) inhibition. The firm reported positive Phase Ib results showing a quick, dose-dependent reduction in amyloid.
Scrip Asia 100 - Government support puts companies on the radar
Regional development agencies (RDAs) and other government organisations play a major role in driving commercial and scientific success.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- ADMET
- Bioinformatics
- Genomics-Proteomics
-
Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice